Noncompliance is often not a failure of knowledge or intention, but a predictable response to cognitive overload. Effective ...
And in a phase III trial win, Foresee Pharmaceuticals said its long-acting gonadotropin-releasing hormone agonist leuprolide ...
The Naox Link in-ear EEG platform is the first of its kind to be cleared for prescription use at home or in healthcare ...
On the treatment side, more people with COVID should receive outpatient antiviral therapies that prevent hospitalization and ...
Furthermore, GLP-1 drugs had a favorable safety profile versus aspirin, particularly with respect to bleeding events, said ...
Health and Human Services Secretary Robert F. Kennedy Jr. is putting children's health and lives at risk in the name of ...
The problem with daily aspirin use is the risk of bleeding, as seen time and time again in major randomized trials. In the ...
SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...
The first GLP-1 pill for obesity, semaglutide (Wegovy) tablets from drugmaker Novo Nordisk, launched in the U.S. ( CNBC) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback